This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Idexx Laboratories (IDXX)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 187.79M 178.29M 161.75M 141.32M
Operating Gains/Losses 170.00K -3.27M 615.00K -1.40M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -15.95M 3.49M -24.81M -6.91M
(Increase) Decrease in Inventories -1.35M -13.75M -6.31M -19.47M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -4.40M -1.30M 13.88M 3.48M
(Decrease) Increase In Other Current Liabilities 16.51M 3.01M 17.56M 30.60M
(Increase) Decrease In Other Working Capital 2.12M 10.82M 6.00M -10.84M
Other Non-Cash Items 4.43M 2.57M -2.20M -3.00M
Net Cash From Continuing Operations 246.00M 230.28M 220.70M 178.83M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 246.00M 230.28M 220.70M 178.83M
Sale of Property, Plant & Equipment 3.50M 45.00K 225.00K 112.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -78.64M -66.39M -53.46M -39.30M
Acquisitions -10.92M 342.00K -43.76M 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 -4.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -86.06M -66.00M -97.00M -43.19M
Issuance of Debt 150.00M 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 38.24M 24.17M 28.80M 28.86M
Repayment of Long-Term Debt -1.11M -917.00K -863.00K -813.00K
Repurchase of Capital Stock -367.76M -132.27M -255.50M -143.09M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 78.18M -16.32M 129.91M 28.27M
Net Cash From Financing Activities -102.45M -125.34M -97.66M -86.77M
Effect of Exchange Rate Changes -2.41M 1.16M 933.00K 1.31M
Net Change in Cash & Cash Equivalents 55.07M 40.09M 26.98M 50.19M

IDXX Idexx Laboratories

Analysts Ratings for IDXX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2

Brokerage Partners

IDXX Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs